A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN
Clinical trial NCT04667013 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04667013
- Sponsor
- Guangzhou Magpie Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-03-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.